Ichikado, Kazuya
Ichiyasu, Hidenori
Iyonaga, Kazuhiro
Kawamura, Kodai
Higashi, Noritaka
Johkoh, Takeshi
Fujimoto, Kiminori
Morinaga, Jun
Yoshida, Minoru
Mitsuzaki, Katsuhiko
Suga, Moritaka
Tanabe, Naoya
Handa, Tomohiro
Hirai, Toyohiro
Sakagami, Takuro
Article History
Received: 23 February 2023
Accepted: 26 April 2023
First Online: 8 June 2023
Declarations
:
: KIchi, HI, TJ, and TS received lecture fees from Nippon Boehringer Ingelheim Co. Ltd. NT, THan, and THir have received research grants from FUJIFILM Corporation. THan is employed by Collaborative Research Laboratory funded by Teijin Pharma Co., Ltd. KIyo, KK, NH, KF, JM, MY, KM, and MS have no conflicts of interest to declare.
: This study protocol and informed consent documents have been approved by the Institutional Review Boards of Kumamoto University Hospital (approval number: 2368), Saiseikai Kumamoto Hospital (approval number: 809), and each participating institution. Additionally, written informed consent will be obtained from all participants. Patient recruitment commenced on 20 June 2022. When we use human tissue or blood samples, all methods were carried out in accordance with relevant guidelines and regulations.
: Informed consent including the use of personal examination data or images will be obtained from all participants. If we cite personal data such as text/figures/tables/images, we strictly do anonymization not to identify the participants themselves.